a Subsidiary of HITCO Holding
Novin Darou Zist Fanavar Haraz, a subsidiary of HITCO Holding, is dedicated to pharmaceutical manufacturing and committed to advancing healthcare solutions. Established in 2017 in Amol by scientists from the Pasteur Institute of Iran, Novin Darou focuses on producing blood plasma derivatives for patient treatment. The company operates the Novin Darou Plasma Donation Center under the supervision of Pasteur Institute's scientific members, holding a license from the Food and Drug Administration of the Ministry of Health for plasma collection in Amol.
Novin Darou Zist Fanavar Haraz aims to create a framework for producing human plasma-derived immunoglobulin to treat rabies and hepatitis B. The company has a pipeline of diverse products planned for commercialization and market introduction, reflecting its commitment to expanding its healthcare offerings.
With a focus on innovation and quality, Novin Darou Zist Fanavar Haraz is poised for continued growth and development in the pharmaceutical industry. We invite the manager of Novin Darou Zist Fanavar Haraz to create a customized and exclusive company showcase and product listing on our platform to further highlight your capabilities and reach a wider audience.
Other organizations in the same industry
This company is also known as